Immune response and infections in children and newborns
Treatments studied
Part of Infections clinical trials.
This study looks at how the body's immune system responds to infections like malaria and other germs, especially in young children and newborns. By comparing children with and without fever, and mothers and their newborns, researchers hope to understand how co-infections affect health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 6 months and 5 years old (6 to 60 months).
- If your child has a fever, it has lasted less than 7 days and is at least 37.5°C (measured under the arm).
- If your child does not have a fever, they have had no fever or infection for at least 7 days.
- Pregnant women can join if they are delivering at a partner health center, have a single baby, and no serious health conditions like diabetes or high blood pressure.
- Newborns can join if they are born full-term and their family plans to stay in the study area during follow-up.
- You (or your child) cannot be participating in another research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people get malaria during pregnancy, and how young children’s bodies respond early in life. It may help researchers understand who is more likely to get malaria and why, which could guide future prevention and care.
This study looks at how malaria spreads in Mozambique by testing children and pregnant women with fever. If you or your child may have malaria, participating could help researchers understand and fight the disease better.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This trial is testing a new blood test to help doctors tell which babies under three months with fever are at risk for a serious bacterial infection. If successful, it could help avoid unnecessary antibiotics and hospital stays.
This study is testing a new, fast test to better identify which young children with fever are at risk for serious illness. If your child is eligible, they will be part of a group that helps doctors decide how to treat febrile children more accurately.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.